Status:
UNKNOWN
Digital Patient Education Platform in Head and Neck Cancer
Lead Sponsor:
University of British Columbia
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Head and neck cancer is a disease that has a particular propensity for treatment-related morbidity. It is hypothesized that patients who are more involved in their care in hospital and who are activel...
Eligibility Criteria
Inclusion
- Patients aged 19 years old or above
- Patients seen in outpatient clinic who are scheduled to undergo reconstructive head and neck surgeries for a confirmed oral or oropharyngeal cancer diagnosis.
Exclusion
- Patients who are unable to use a digital tablet
- Patients who do not speak or read English
- Individuals unable to understand the purpose, methods and conduct of this study
- Patients unwilling to provide informed consent
Key Trial Info
Start Date :
January 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05211778
Start Date
January 8 2019
End Date
June 1 2022
Last Update
January 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital
Vancouver, British Columbia, Canada